Company Overview and News

 
Kenanga issues four new O&G warrants as oil breaches US$80

2018-10-01 theedgemarkets
KUALA LUMPUR (Oct 1): Kenanga Investment Bank Bhd (KIBB) has issued four new structured warrants covering the O&G sector, just as Brent crude oil prices surpassed US$80 a barrel this week.
0166 BRDBF 7022 5012 GBTKF 5210

 
Demand for CPO expected to pick up towards 4Q of 2018

2018-09-14 theedgemarkets
Plantation sector Maintain neutral: Malaysia’s crude palm oil (CPO) production increased for a second straight month in August, rising by 7.9% month-on-month (m-o-m) to 1.62 million tonnes. The fresh fruit bunch (FFB) yield also improved across Peninsular Malaysia, Sabah and Sarawak, rising by 8.7%, 3.2% and 12.6% year-on-year (y-o-y) respectively to 1.38 tonnes/ha, 1.28 tonnes/ha and 1.52 tonnes/ha.
KLKBY 2445 5138 2216 4383 2291 4243 5012

 
Worst may be over for Ta Ann’s timber business

2018-09-05 theedgemarkets
TA Ann Holdings Bhd’s timber business, which has been loss-making for the past three consecutive quarters, may have turned a corner.
5135 5012

 
Ta Ann may rebound further, says RHB Retail Research

2018-09-03 theedgemarkets
KUALA LUMPUR (Sept 3): RHB Retail Research said Ta Ann Holdings Bhd may rebound further after it tested MYR2.56 support in recent trades.
5012

 
Oil palm planters’ earnings seen improving in 2H

2018-08-27 theedgemarkets
KUALA LUMPUR: Plantation companies listed on the local bourse turned in weaker corporate earnings in the three months ended June 30, 2018, but analysts are positive about seeing improvements in the remaining months of the year.
5012

 
Ta Ann’s log export volumes seen to rise next two years

2018-08-24 theedgemarkets
Ta Ann Holdings Bhd (Aug 23, RM2.72) Maintain outperform call with an unchanged target price (TP) of RM3.19: Log prices have gradually climbed from US$276 per cubic metre (cu m) in second quarter of financial year 2017 (2QFY17) to US$368 (RM1,512.48) per cu m in 2QFY18, a whopping gain of 33% year-on-year (y-o-y).
5012

 
Analyst Reports

2018-07-09 thestar.com.my
CGSCIMB recently hosted Inari Amertron’s management on a roadshow in London. The research house said it had with 10 buy-side analysts and fund managers from eight investment firms. Inari Amerton was represented by group chief executive officer K.C. Lau and founder and executive director P.G. Ho.
0166 5012

 
MISC, Red Sena, Top Glove, KUB Malaysia, Ta Ann, Protasco and Versatile Creative

2018-07-06 theedgemarkets
KUALA LUMPUR (July 6): Based on corporate announcements and news flow today, stocks that may draw some attention on Monday (July 9) could be MISC, Red Sena, Top Glove, KUB Malaysia, Ta Ann, Protasco and Versatile Creative.
TGLVY 4995 5270 7113 TPGVF 6874 BSMAF 5012 1818

 
Ta Ann gets sustainable timber management certification for its local operations

2018-07-06 theedgemarkets
KUALA LUMPUR (July 6): Ta Ann Holdings Bhd has received its first ever sustainable forest management certification for its Malaysian operations, for its forest plantation in Sarawak.
5012

16
Planters get apprehensive as CPO prices fall

2018-06-22 thestar.com.my
PLANTERS will likely face tough sales and operational conditions following the drastic fall in crude palm oil (CPO) prices, which had been trading below RM2,300 per tonne level in recent weeks.
KLKBY 2445 WLMIY WLMIF SMEBF 4197 F34 5222 5012

2
KL Plantation Index down to eight-year low

2018-06-21 thestar.com.my
Despite climbing 11.83 points to 13,184.84 yesterday, the plantation index was at its lowest since October 2010. Analysts said the multi-year low was in tandem with CPO prices that has been trending downwards.
2291 9059 5012

 
Stormy quarter puts pressure on Ta Ann’s cash flow

2018-06-13 theedgemarkets
BAD luck and ongoing timber woes are sapping the cash reserves of Ta Ann Holdings Bhd, which paid nearly RM171 million for 30.4% of Sarawak Plantation Bhd (SPLB) earlier this year.
5135 5012

 
Further increase in export prices of plywood seen

2018-06-11 thestar.com.my
Export prices for Sarawak plywood products to Japan have risen over 10% since late last year, and further increases are on the cards.
4243 5012

 
Ta Ann expands plantation log harvest for plywood

2018-05-27 thestar.com.my
According to group managing director and CEO Datuk Wong Kuo Hea, Ta Ann has stepped up its reforestation programme and raised its planted forest to 35,141ha at end-2017.
5012

3
Planters face wage squeeze

2018-05-18 thestar.com.my
THE labour-intensive oil palm sector will likely face margin pressures from Pakatan Harapan’s election manifesto for a higher minimum wage and to reduce dependence on foreign labour, say analysts.
9059 5222 5012

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...